Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhan Deng

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Chemical Biology & Drug Design|August 3, 2006
A kinase-focused compound collection: compilation and screening strategyDongyu Sun, Claudio Chuaqui, Zhan Deng, et al.
Current Opinion in Drug Discovery & Development|April 23, 2008
Which aspects of HTS are empirically correlated with downstream success?Andreas Bender, Dejan Bojanic, John W Davies, et al.
World Journal of Gastroenterology|September 26, 2022
Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinomaPeng-Zhan Deng, Bi-Geng Zhao, Xian-Hui Huang, et al.
Protein Science : a Publication of the Protein Society|August 28, 2010
A lead discovery strategy driven by a comprehensive analysis of proteases in the peptide substrate spaceSai Chetan K Sukuru, Florian Nigsch, Jean Quancard, et al.
ACS Chemical Biology|October 8, 2016
Discovery and Characterization of Allosteric WNK Kinase InhibitorsKen Yamada, Ji-Hu Zhang, Xiaoling Xie, et al.
Cell Chemical Biology|July 25, 2020
Systematic Chemogenetic Library AssemblyStephen M Canham, Yuan Wang, Allen Cornett, et al.
Journal of Medicinal Chemistry|June 28, 2016
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase InhibitorJorge Garcia Fortanet, Christine Hiu-Tung Chen, Ying-Nan P Chen, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Chemical Biology & Drug Design|August 3, 2006
A kinase-focused compound collection: compilation and screening strategyDongyu Sun, Claudio Chuaqui, Zhan Deng, et al.
Current Opinion in Drug Discovery & Development|April 23, 2008
Which aspects of HTS are empirically correlated with downstream success?Andreas Bender, Dejan Bojanic, John W Davies, et al.
World Journal of Gastroenterology|September 26, 2022
Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinomaPeng-Zhan Deng, Bi-Geng Zhao, Xian-Hui Huang, et al.
Protein Science : a Publication of the Protein Society|August 28, 2010
A lead discovery strategy driven by a comprehensive analysis of proteases in the peptide substrate spaceSai Chetan K Sukuru, Florian Nigsch, Jean Quancard, et al.
ACS Chemical Biology|October 8, 2016
Discovery and Characterization of Allosteric WNK Kinase InhibitorsKen Yamada, Ji-Hu Zhang, Xiaoling Xie, et al.
Cell Chemical Biology|July 25, 2020
Systematic Chemogenetic Library AssemblyStephen M Canham, Yuan Wang, Allen Cornett, et al.
Journal of Medicinal Chemistry|June 28, 2016
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase InhibitorJorge Garcia Fortanet, Christine Hiu-Tung Chen, Ying-Nan P Chen, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Pageof 2